Immunohistochemistry in Diagnostic Parathyroid Pathology

被引:77
作者
Erickson, Lori A. [1 ]
Mete, Ozgur [2 ]
机构
[1] Mayo Clin, Dept Lab Med & Pathol, 200 First St SW, Rochester, MN 55905 USA
[2] Univ Hlth Syst, Dept Pathol, Lab Med Program, Toronto, ON, Canada
关键词
Parathyroid; Parafibromin; Parathyroid carcinoma; Atypical parathyroid adenoma; Parathyroid hormone; Immunohistochemistry; TRANSCRIPTION FACTOR-I; JAW TUMOR SYNDROME; FAMILIAL ISOLATED HYPERPARATHYROIDISM; ECTOPIC PARATHORMONE PRODUCTION; CYCLIN D1/PRAD1 EXPRESSION; NEUROENDOCRINE TUMORS; TTF-1; EXPRESSION; SUPPRESSOR GENE; PARAFIBROMIN IMMUNOREACTIVITY; SECONDARY HYPERPARATHYROIDISM;
D O I
10.1007/s12022-018-9527-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pathologists are usually readily able to diagnose parathyroid tissues and diseases, particularly when they have knowledge of the clinical information, laboratory findings, and radiographic imaging studies. However, the identification of parathyroid tissue or lesions can be difficult in small biopsies, ectopic locations, supranumerary glands, and in some oxyphil/oncocytic lesions. Widely available immunohistochemical studies such as chromogranin-A, synaptophysin, keratin, parathyroid hormone, thyroglobulin, and thyroid transcription factor-1 can help in difficult cases. One of the most difficult diagnostic aspects faced by the pathologist in evaluating parathyroid is distinguishing between parathyroid adenoma, particularly atypical adenoma, and parathyroid carcinoma. Many markers have and continue to be evaluated for diagnostic utility, and are even beginning to be studied for prognostic utility. Single immunohistochemical markers such as parafibromin and Ki-67 are among the most studied and most utilized, but many additional markers have and continue to be evaluated such as galectin-3, PGP9.5, Rb, bcl2, p27, hTERT, mdm2, and APC. Although not widely available in many laboratories, a panel of immunohistochemical markers may prove most useful as an adjunct in the evaluation of challenging parathyroid tumors.
引用
收藏
页码:113 / 129
页数:17
相关论文
共 103 条
[1]   Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors [J].
Agoff, SN ;
Lamps, LW ;
Philip, AT ;
Amin, MB ;
Schmidt, RA ;
True, LD ;
Folpe, AL .
MODERN PATHOLOGY, 2000, 13 (03) :238-242
[2]   Molecular Profiling of Parathyroid Hyperplasia, Adenoma and Carcinoma [J].
Arvai, Kristof ;
Nagy, Katalin ;
Barti-Juhasz, Helga ;
Petak, Istvan ;
Krenacs, Tibor ;
Micsik, Tamas ;
Vegso, Gyula ;
Perner, Ferenc ;
Szende, Bala .
PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (03) :607-614
[3]   Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors - Diagnostic implications [J].
Bakshi, Nasir ;
Kunju, Lakshmi P. ;
Giordano, Thomas ;
Shah, Rajal B. .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2007, 15 (03) :310-315
[4]   Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases [J].
Bergero, N ;
De Pompa, R ;
Sacerdote, C ;
Gasparri, G ;
Volante, M ;
Bussolati, G ;
Papotti, M .
HUMAN PATHOLOGY, 2005, 36 (08) :908-914
[5]   TTF-1 Expression in Nephroblastoma [J].
Bisceglia, Michele ;
Ragazzi, Moira ;
Galliani, Carlos A. ;
Lastilla, Gaetano ;
Rosai, Juan .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (03) :454-461
[6]   PARANEOPLASTIC HYPERCALCEMIA ASSOCIATED WITH ADENOSQUAMOUS CARCINOMA OF THE ENDOMETRIUM [J].
BULLER, R ;
TAYLOR, K ;
BURG, AC ;
BERMAN, ML ;
DISAIA, PJ .
GYNECOLOGIC ONCOLOGY, 1991, 40 (01) :95-98
[7]   HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome [J].
Carpten, JD ;
Robbins, CM ;
Villablanca, A ;
Forsberg, L ;
Presciuttini, S ;
Bailey-Wilson, J ;
Simonds, WF ;
Gillanders, EM ;
Kennedy, AM ;
Chen, JD ;
Agarwal, SK ;
Sood, R ;
Jones, MP ;
Moses, TY ;
Haven, C ;
Petillo, D ;
Leotlela, PD ;
Harding, B ;
Cameron, D ;
Pannett, AA ;
Höög, A ;
Heath, H ;
James-Newton, LA ;
Robinson, B ;
Zarbo, RJ ;
Cavaco, BM ;
Wassif, W ;
Perrier, ND ;
Rosen, IB ;
Kristoffersson, U ;
Turnpenny, PD ;
Farnebo, LO ;
Besser, GM ;
Jackson, CE ;
Morreau, H ;
Trent, JM ;
Thakker, RV ;
Marx, SJ ;
Teh, BT ;
Larsson, C ;
Hobbs, MR .
NATURE GENETICS, 2002, 32 (04) :676-680
[8]   Genetic analyses of the HRPT2 gene in primary hyperparathyroidism:: Germline and somatic mutations in familial and sporadic parathyroid tumors [J].
Cetani, F ;
Pardi, E ;
Borsari, S ;
Viacava, P ;
Dipollina, G ;
Cianferotti, L ;
Ambrogini, E ;
Gazzerro, E ;
Colussi, G ;
Berti, P ;
Miccoli, P ;
Pinchera, A ;
Marcocci, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11) :5583-5591
[9]   Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? [J].
Cetani, Filomena ;
Ambrogini, Elena ;
Viacava, Paolo ;
Pardi, Elena ;
Fanelli, Giovanni ;
Naccarato, Antonio Giuseppe ;
Borsari, Simona ;
Lemmi, Monica ;
Berti, Piero ;
Miccoli, Paolo ;
Pinchera, Aldo ;
Marcocci, Claudio .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (05) :547-554
[10]   CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer [J].
Cetani, Filomena ;
Banti, Chiara ;
Pardi, Elena ;
Borsari, Simona ;
Viacava, Paolo ;
Miccoli, Paolo ;
Torregrossa, Liborio ;
Basolo, Fulvio ;
Pelizzo, Maria Rosa ;
Rugge, Massimo ;
Pennelli, Gianmaria ;
Gasparri, Guido ;
Papotti, Mauro ;
Volante, Marco ;
Vignali, Edda ;
Saponaro, Federica ;
Marcocci, Claudio .
ENDOCRINE CONNECTIONS, 2013, 2 (04) :186-195